Mar 25Alpha Tau to Present at the Jefferies Radiopharma Innovation SummitJERUSALEM, March 25, 2024 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Mar 8Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update- Positive interim safety and feasibility data from pancreatic cancer study in Montreal, with initial signs of potential dose response...
Feb 26Alpha Tau to Participate in Barclays 26th Annual Global Healthcare ConferenceJERUSALEM, February 26, 2024 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Dec 20, 2023Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference- The overview presentation will review some of the Company’s recent achievements, including highly promising interim results from the...
Nov 29, 2023Alpha Tau to Participate in Sidoti Small-Cap ConferenceJERUSALEM, November 29, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...